High-Dose Drug-Coated Balloon Versus Polymer-Based Drug-Eluting Stent for Femoropopliteal Artery Disease Treatment.

Yoshimitsu SogaMitsuyoshi TakaharaOsamu Iida Yusuke Tomoi Daizo Kawasaki Masahiko Fujihara Amane KozukiAkiko TanakaYasutaka YamauchiKazuki TobitaTerutoshi YamaokaShigeo IchihashiKenji Ando

Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2024)

One-year restenosis rate was significantly lower in the polymer-based DES group than in the high-dose DCB group for foemoropopliteal disease. However, there is no difference in the other endpoints between two groups.

Keyphrases

high dose
low dose
stem cell transplantation
emergency department
peripheral artery disease